Sen. Amy Klobuchar (D–MN) is pressuring six pharma companies to remove improperly listed patents from the FDA’s Orange Book by the end of the …
Full story here.
Published by endpts.com
Visited 1 times, 1 visit(s) today
AstraZeneca, Boehringer Ingelheim, GSK defend patent listings as Klobuchar amps up pressure
